Abstract:OBJECTIVE:To explore the circadian blood pressure (BP) profile and its influencing factors in essential hypertensive patients after treatment. METHODS:Cross-sectional surveillance was carried out in essential hypertensive subjects after treatment whose clinic blood pressure had been under control as 140/90 mm Hg (1 mm Hg = 0.133 kPa) for at least one month. All patients underwent a twenty-four-hour ambulatory blood pressure monitoring device (spacelabs 90207). The nocturnal fall of blood pressure (BP) was calculated from (daytime mean BP-night-time mean BP)/daytime BP, while 'daytime' values were recorded between 6 h and 22 h and 'night-time' values between 22 h and 6 h. Non-dippers were defined as those whose nocturnal decrease in mean systolic BP and/or mean diastolic BP was < 10% of the daytime BP. Binary logistic regression analysis was used to evaluate the correlation between circadian blood pressure profile and factors as gender, age, height, body mass index (BMI), family history of premature cardiovascular disease, women under age 65 or men under age 55, smoking habits, grade of hypertension, and strategy of antihypertensive drugs. RESULTS:208 treated essential hypertensive patients were enrolled in the study. 79 individuals were dippers and 129 were non-dippers. Data from logistic regression analysis showed that four factors as age, premature family history of cardiovascular disease, overweight or obesity, and strategy of antihypertensive drugs were significantly influencing the circadian blood pressure profile in treated hypertensive patients. The incidence of non-dippers in patients of 70 years of age or older and those between 60 and 69 were 3.3 and 2.3 times of those with less than 60 (P = 0.009 and 0.031, respectively). The prevalence of non-dippers in patients with a premature family history of cardiovascular disease was 3.7 times greater than those in subjects without a premature history of cardiovascular disease (P = 0.029). Similarly, the incidence of non-dippers in patients of overweight (24 = BMI < 28) and obesity (BMI >/= 28) were 3.0 and 4.8 times of those in subjects of normal weight (P = 0.003 and 0.009, respectively). Compared with patients treated with long-acting calcium channel blockers (CCBs), patients treated with angiotensin-converting enzyme (ACE) inhibitors or angiotensin II receptor blockers (ARBs) alone had less prevalence of nondippers (OR = 0.139, P = 0.010). Patients treated with joint antihypertensive scheme including ACE inhibitors or ARBs(but not including diuretics) had the tendency of lower incidence of abnormal circadian blood pressure rhythm (OR = 0.453, P = 0.118). Patients treated with joint antihypertensive scheme including diuretics (not including ACE inhibitors or ARBs) and with joint antihypertensive strategy including diuretics and ACE inhibitors or ARBs had lower incidence of nondippers (OR = 0.378 and 0.273, respectively; P = 0.030 and 0.011, respectively). CONCLUSIONS:Approximately 2/3 treated essential hypertensive patients had a non-dipper blood pressure profile. Age, premature family history of cardiovascular disease, overweight/obesity, and antihypertensive drugs strategy were correlated with circadian blood pressure profile. Compared with long-acting CCBs, diuretics, ACE inhibitors or ARBs might be helpful in keeping the circadian blood pressure rhythm at normal range.

Features of Allostatic Load in Patients with Essential Hypertension without Metabolic Syndrome Depending on the Nature of Nighttime Decreases in Blood Pressure

Profile on Circadian Blood Pressure and the Influencing Factors in Essential Hypertensive Patients after Treatment

THE PRONOSTIC VALUE OF NOCTURNAL BLOOD PRESSURE IN UNTREATED ADULT HYPERTENSIVES FROM ALGERIAN POPULATION

Allostatic overload in patients with essential hypertension

ENHANCING NOCTURNAL BLOOD PRESSURE ASSESSMENT THROUGH HYDROSTATIC PRESSURE CORRECTION: A CLINICAL STUDY

P065 NOCUTRNAL BLOOD PRESSURE AND ITS CLINICAL CLASSIFICATION ARE GREATLY AFFECTED BY HYDROSTATIC PRESSURE AND POSTURAL CHANGES BETWEEN MEASUREMENTS

A8629 Isolated Nocturnal Hypertension and Its Association with Subclinical Target Organ Damage in Untreated Chinese Patients

PREVALENCE AND RISK FACTORS OF ALTERED CONTROL OF BP DURING THE NIGHT IN A LARGE HEMODIALYSIS POPULATION INVESTIGATED BY 48 HOURS ABPM

[OP.6B.01] TWENTY-FOUR HOUR BLOOD PRESSURE PROFILE AND LEFT VENTRICULAR HYPERTROPHY IN HYPERTENSIVE PATIENTS WITH PRIMARY ALDOSTERONISM

Diurnal blood pressure pattern and cardiac damage in hypertensive patients with primary aldosteronism

Association of Nighttime Systolic Blood Pressure With Left Atrial-Left Ventricular–Arterial Coupling in Hypertension

Impact of various night-time period definitions on nocturnal ambulatory blood pressure

Ambulatory blood pressure measurement in patients with chronic kidney disease

Different Relevance of Peripheral, Central or Nighttime Blood Pressure Measurements in the Prediction of Chronic Kidney Disease Progression in Patients with Mild or No-Proteinuria

Isolated nocturnal hypertension and arterial stiffness in a Chinese population.

Prognostic Value of Isolated Nocturnal Hypertension on Ambulatory Measurement in 8711 Individuals from 10 Populations

Prognostic Accuracy of Day Versus Night Ambulatory Blood Pressure: a Cohort Study.

HOME BLOOD PRESSURE DURING NIGHT-TIME SLEEP AS A BETTER TREATMENT TARGET FOR PATIENTS WITH HYPERTENSOIN: A PROOF-OF-CONCEPT RANDOMIZED CONTROLLED TRIAL

Blood Pressure Load Does Not Add to Ambulatory Blood Pressure Level for Cardiovascular Risk Stratification

Abstract 13243: Different Efficacy of Angiotensin Receptor Blockers for Nocturnal Blood Pressure Reduction in Patients with Mild to Moderate Hypertension: A Systematic Review and Meta-Analysis

Circulating angiotensin-(1–7) is decreased in patients with isolated nocturnal hypertension